Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma

March 7, 2006 |

Biochemical and Biophysical Research Communications. Received 11 February 2006.  Available online 24 February 2006. [Link] Sonny Batraa, Yihui Shia, Kristopher M. Kuchenbeckera, Biao Hea, Noemi Reguarta, b, Iwao Mikamia, Liang…

Macroscopic, Histologic, Histochemical, Immunohistochemical, and Ultrastructural Features of Mesothelioma

March 7, 2006 |

Ultrastructural Pathology. 2006 Jan-Feb;30(1):3-17. [Link] Hammar SP. Diagnostic Specialties Laboratories, Bremerton, Washington, USA. Abstract Mesotheliomas are uncommon neoplasms that arise from the cells forming the serosal membranes of the body…

Biologic, Cytogenetic, and Molecular Factors in Mesothelial Proliferations

March 7, 2006 |

Ultrastructural Pathology. 2006 Jan-Feb;30(1):19-30. [Link] John Hicks A1 A1 Department of Pathology, Texas Children’s Hospital and Baylor College of Medicine, Houston, Texas, USA Abstract Although mesothelioma cases may have peaked in…

The Role of Analytical SEM in the Determination of Causation in Malignant Mesothelioma

March 7, 2006 |

Ultrastructural Pathology. 2006 Jan-Feb;30(1):31-5. [Link] Victor L. Roggli A1 A1 Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA Abstract The causative relationship between asbestos exposure and mesothelioma is…

Phosphorylated Extracellular Signal-regulated Kinases are Significantly Increased in Malignant Mesothelioma

March 7, 2006 |

Journal of Histochemistry & Cytochemistry. 2006 Mar 3; [Epub ahead of print] [Link] Merivane de Melo 1, Margaret W. Gerbase 1, Joseph Curran 1 and Jean-Claude Pache 1* 1 Divisions…

Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic Acid

March 6, 2006 |

Clinical Lung Cancer. 2006 Jan;7(4):257-61. [Link] Krug LM, Curley T, Schwartz L, Richardson S, Marks P, Chiao J, Kelly WK. Thoracic Oncology Service , Memorial Sloan-Kettering Cancer Center and Joan…

The expression pattern of beta-catenin in mesothelial proliferative lesions and its diagnostic utilities

March 2, 2006 |

Diagnostic Cytopathology. Volume 33, Issue 5 , Pages 320 – 324. Published Online: 20 Oct 2005. [Link] Yiran Dai, M.D. 1 *, Carlos W.M. Bedrossian, M.D., FIAC 2, Claire W.…

Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura

March 2, 2006 |

Journal of Clinical Pathology. 2006 Mar;59(3):250-4. [Link] Soini Y, Kinnula V, Kahlos K, Paakko P. Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland. Abstract Aim: To…

Occupational asbestos exposure: how to deal with suspected mesothelioma cases–the Dutch approach

February 28, 2006 |

Annals of Oncology. Published online on February 24, 2006. [Link] P. Baas 1 *, N. van ‘t Hullenaar 2, J. Wagenaar 3, J. P. G. Kaajan 4, M. Koolen 5,…

Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors

February 28, 2006 |

Annals of Oncology. Published online on February 24, 2006 [Link] H. Richly 1, B. F. Henning 2, P. Kupsch 1, K. Passarge 1, M. Grubert 1, R. A. Hilger 1,…

Categories